Clinical OMICS

MAR-APR 2019

Healthcare magazine for research scientists, labs, pathologists, hospitals, cancer centers, physicians and biopharma companies providing news articles, expert interviews and videos about molecular diagnostics in precision medicine

Issue link: https://clinicalomics.epubxp.com/i/1093879

Contents of this Issue

Navigation

Page 20 of 51

www.clinicalomics.com March/April 2019 Clinical OMICs 19 I n 2014, a decade after the completion of the Human Genome Project, Clinical OMICs was launched as a new sister publication to Genetic Engineering & Biotechnology News. Over the past five years, the magazine has covered a wide range of exciting stories spanning new diagnostics technologies, the role of biomarker discovery in drug development, advances in sequencing and other omics platforms and their integration into the clinic, as well as the regulatory and economic issues that must be addressed to deliver the full promise of precision medicine. In this 5th Anniversary special report, we invited leading authorities in personalized medicine to review the major advances in our industry over the past five years and look ahead to the next five. Senior Editor Alex Philippidis looks at five successful companies that epitomize the suc- cessful evolution of molecular diagnostics and personalized medicine. The section also includes sponsored contributions from leading companies in this space. We've had a blast covering this field over the past five years and can't wait to see what the next five brings.—Chris Anderson A digital publication of GEN, a Mary Ann Liebert, Inc. company APRIL 23, 2014 ISSUE No. 1 Translating OMICs into Cancer Biology and Medicine Payers Wrestle with Reimbursement Best New Clinical Apps Innovator: Lawrence Brody New Products & More Translating OMICs into Cancer Biology and Medicine Payers Wrestle with Reimbursement Best New Clinical Apps Innovator: Lawrence Brody New Products & More Innovative Practices, Actionable Results MAY 29, 2014 ISSUE No. 4 A digital publication of GEN, a Mary Ann Liebert, Inc. company Cancer Diagnostics Leverage Decreasing Cost of Sequencing Labs Face Medicare Cuts, New Codes Exosomes Patenting Medical Diagnostics New Products & More Cancer Diagnostics Leverage Decreasing Cost of Sequencing Labs Face Medicare Cuts, New Codes Exosomes Patenting Medical Diagnostics New Products & More Innovative Practices, Actionable Results Honing Prenatal Screening Tests Near or Far? Omics Data Management, Analysis, and Action Smartphone Based Biosensors —Just What the mDiagnostician Ordered Events Roundup, New Products & More Honing Prenatal Screening Tests Near or Far? Omics Data Management, Analysis, and Action Smartphone Based Biosensors —Just What the mDiagnostician Ordered Meeting Roundup, New Products & More SEPTEMBER 10, 2014 ISSUE No. 9 A digital publication of GEN, a Mary Ann Liebert, Inc. company Innovative Practices, Actionable Results NOVEMBER/DECEMBER 2017 VOL. 4, ISSUE No. 6 Stephen Kingsmore Speeds Forward POC Testing Revs Up Unlocking the Microbiome GTEx Links Variants to Expression Stephen Kingsmore Speeds Forward POC Testing Revs Up Unlocking the Microbiome GTEx Links Variants to Expression SEPTEMBER/OCTOBER 2017 VOL. 4, ISSUE No. 5 CRISPR Competition Heats Up Of Biomarkers and CDxes Machine Learning Pitfalls Hijacking Computers with DNA CRISPR Competition Heats Up Of Biomarkers and CDxes Machine Learning Pitfalls Hijacking Computers with DNA DECEMBER 10, 2014 ISSUE No. 15 A digital publication of GEN, a Mary Ann Liebert, Inc. company Molecular Diagnostics in Personalized Medicine Noninvasive Molecular Diagnostics for Cancer Genomic Medicine: Balancing Cost and Value The National Access Project for Cancer Testing Meeting Roundup New Products & More Noninvasive Molecular Diagnostics for Cancer Genomic Medicine: Balancing Cost and Value The National Access Project for Cancer Testing Meeting Roundup New Products & More Noninvasive Molecular Diagnostics for Cancer Genomic Medicine: Balancing Cost and Value The National Access Project for Cancer Testing Meeting Roundup New Products & More A digital publication of GEN, a Mary Ann Liebert, Inc. company JULY/AUGUST 2017 VOL. 4, ISSUE No. 4 Clinical Genomics Leader Heidi Rehm Talks Shop NIPT Eyes Single-Cell Techniques NGS Diagnostics Come of Age Geisinger's MyCode Powers Precision Medicine Clinical Genomics Leader Heidi Rehm Talks Shop NIPT Eyes Single-Cell Techniques NGS Diagnostics Come of Age Geisinger's MyCode Powers Precision Medicine Molecular Diagnostics in Personalized Medicine VOL. 6, ISSUE NO. 1 JANUARY/FEBRUARY 2019 England's NHS Rolls Out Countrywide Genomic Medicine Service Epigenetics Inches Toward the Clinic Challenges of CDx Development Mount Sinai's Precision Push A Larger Role for Genomics in Immuno-Oncology Liquid Biopsy Gets Ready for Prime Time CRUK Funds Four Grand Challenge Teams Molecular Diagnostics in Personalized Medicine MARCH/APRIL 2017 VOL. 4, ISSUE No. 2 A Larger Role for Genomics in Immuno-Oncology Liquid Biopsy Gets Ready for Prime Time CRUK Funds Four Grand Challenge Teams Nanopore Sequencing: The New Front Line of Infectious Disease Diagnostics Point-of-Care Molecular Diagnostics Evolve CASE STUDY: Taking Control of Operational Genomics New Products & More JULY 2015 VOL. 2, ISSUE No. 7 Molecular Diagnostics in Personalized Medicine Nanopore Sequencing: The New Front Line of Infectious Disease Diagnostics Point-of-Care Molecular Diagnostics Evolve CASE STUDY: Taking Control of Operational Genomics New Products & More A digital publication of GEN, a Mary Ann Liebert, Inc. company FEBRUARY 2015 VOL. 2, ISSUE No. 2 Molecular Diagnostics in Personalized Medicine Beyond the Sequence Uncle Sam Casts Wary Eye on Clinical Lab Billing Case Study: Discovery of Functional Serum Biomarkers Meeting Roundup New Products & More Beyond the Sequence Uncle Sam Casts Wary Eye on Clinical Lab Billing Case Study: Discovery of Functional Serum Biomarkers Meeting Roundup New Products & More Beyond the Sequence Uncle Sam Casts Wary Eye on Clinical Lab Billing Case Study: Discovery of Functional Serum Biomarkers Meeting Roundup New Products & More A digital publication of GEN, a Mary Ann Liebert, Inc. company Researchers Turn to the Cloud as Genomic Data Explodes Advanced Genomic Methods Battle Against Microbial Resistance Coalition Seeks Broader Adoption of NIPT Health Systems Combine EHR and Genomics Data Molecular Diagnostics in Personalized Medicine JANUARY/FEBRUARY 2017 VOL. 4, ISSUE No. 1 Researchers Turn to the Cloud as Genomic Data Explodes Advanced Genomic Methods Battle Against Microbial Resistance Coalition Seeks Broader Adoption of NIPT Health Systems Combine EHR and Genomics Data Commonplace Sequencing Makes Disease Less Rare Industry Awaits Word from FDA on LDTs MD Anderson, Scripps Health Partner for Cancer Care ASCO's CancerLinQ Picks Up Steam Molecular Diagnostics in Personalized Medicine NOVEMBER/DECEMBER 2016 VOL. 3, ISSUE No. 10 Commonplace Sequencing Makes Disease Less Rare Industry Awaits Word from FDA on LDTs MD Anderson, Scripps Health Partner for Cancer Care ASCO's CancerLinQ Picks Up Steam MAY 15, 2014 ISSUE No. 3 A digital publication of GEN, a Mary Ann Liebert, Inc. company Future Cancer Care Anticipating "Panomics" with Bioinformatics Bringing Informed Interpretation to Vexing Variants Best Clinical Apps Innovator: Leroy Hood New Products & More Future Cancer Care Anticipating "Panomics" with Bioinformatics Bringing Informed Interpretation to Vexing Variants Best Clinical Apps Innovator: Leroy Hood New Products & More Innovative Practices, Actionable Results VOL. 5, ISSUE NO. 6 NOVEMBER/DECEMBER 2018 Liquid Logic Circulating Tumor Cells Provide Valuable Insights The Complexity of Metabolomics Experts Predictions for 2019 Community Cancer Care VOL. 5, ISSUE NO. 5 SEPTEMBER/OCTOBER 2018 100,000 Genomes Club New Biomarkers from Wearables More CRISPR Questions Keeping the Beat in Atrial Fibrillation ANNIVERSARY ISSUE th

Articles in this issue

Links on this page

Archives of this issue

view archives of Clinical OMICS - MAR-APR 2019